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ABSTRACT

A method of inducing latency in Mycobacterium permits
preparation of an in vitro model system oflatent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH,
a relatively high level of carbon dioxide and a relatively low
gas phase oxygen level. An in vitro model of mycobacterial
infection employs macrophages induced from THPl cells
which are then infected with Mycobacterium. The infected
macrophages are grown under hypoxic conditions to induce
latency in the mycobacteria. The in vitro model ofinfection is
useful in evaluating compounds for activity against latent
mycobacteria.
6 Claims, 18 Drawing Sheets
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IN VITRO MODEL OF LATENT
MYCOBACTERIAL INFECTION

physiological state and is described as phenotypic resistance.
The phenotypic resistance has been classified into three types
based on the physiological state of bacteria as stationary
phenotypic resistance, persister phenotypic resistance and
phenotypic resistance in dormant bacteria. Mtb displays dormancy-related phenotypic resistance which is demonstrated
by the Cornell mouse model. Traditionally, the phenotypic
resistance is exemplified by resistance to the antibiotic
Rifampicin (Rif) and is regarded as one of the hallmarks of
latent TB. The mechanism of phenotypic resistance in dormant Mtb is not clearly understood.
Development of drugs that can effectively kill dormant
Mtb is of vital importance for the eradication of TB. If such
drugs would prevent the pathogen from surviving in a drugresistant state, a combination of such drugs with currently
used antibiotics could drastically shorten the period of treatment for complete cure and lead to global eradication of TB.
For this purpose, we need to identify processes that are necessary for the pathogen to go into dormancy, survive under the
nonreplicating drug-resistant state, and get reactivated when
the immune system of the host is weakened. Such steps,
essential for the latent pathogen, could offer ideal targets for
novel antilatency drugs that can eliminate the dormant pathogen. To achieve these objectives we explored the biochemical
processes that the pathogen uses to survive for such long
periods under a latent state. It has been known for many
decades that Mtb in the host uses fatty acids as the major
source of energy. It is well known that glyoxylate cycle is used
by organisms that live on fatty acids. In recent years the
important role of isocitrate lyase, a key enzyme uniquely used
in the glyoxylate cycle, was shown to be required for the
persistence ofMtb in the host demonstrating the central role
played by fatty acid catabolism in persistence. However, the
source of fatty acids used by the pathogen remains unclear.
We postulated that the pathogen probably stores energy as
triacylglycerol (TG) as it goes into dormancy and uses this
stored energy to survive the long dormant period at very low
metabolic rates as many living organisms such as hibernating
animals, seeds and spores do for similar purposes. We began
to identify the likely gene products that the pathogen uses to
store TG and to release the fatty acids for catabolism. We also
initiated the development of an in vitro dormancy model to
test the hypothesis that lipid storage and mobilization are of
importance for latency, a model that can be adapted for
screening antilatency drug candidates.
TG is an important storage form of lipid that accumulates
in species belonging to the actinomycetes family, particularly
Mtb. Intracellular TG inclusion bodies were detected in
mycobacteria isolated from organ lesions and Mycobacterium Bovis BCG was reported to preferentially use TG within
macrophages indicating that TG is probably used as an energy
source by Mtb during the course of the disease. We have
shown that TG accumulates when Mtb is subjected to hypoxia
or nitric oxide treatment that led to a dormancy-like state in
culture. We identified fifteen members of a novel class of
diacylglycerol acyltransferase genes which we designated as
tgs (triacylglycerol synthase). Several of the tgs genes were
significantly upregulated under hypoxic conditions and under
nitric oxide treatment, particularly those that show the highest
TG synthase activity when expressed in E. coli. We identified
Rv3130c as the prime gene in the biosynthesis ofTG in the
bacterium under in vitro dormancy-like conditions. Our
hypothesis was strongly supported by a important recent
report on the W /Beijing lineage ofMtb strains which has been
associated with the increasing incidence of multi-drug resistant (MDR) TB epidemic inAsia. The W/Beijing strains were
shown to overproduce TG and the Rv3130c gene was consti-

RELATED APPLICATION
This application is a continuation of U.S. patent application Ser. No. 12/870,945 filed Aug. 30, 2010, now U.S. Pat.
No. 8,241,644, which is a division of application Ser. No.
12/107,146 filed Apr. 22, 2008, now U.S. Pat. No. 8,012,492
priority to said applications is claimed under 35 USC 120.
This application also claims priority to provisional application Ser. No. 60/914,838, which was filed on Apr. 30, 2007,
and which is incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
The present invention relates to the field of infectious diseases and, more particularly, to a pure culture of Mycobacterium which exhibits latency, including resistance to rifampicin and storage of increased lipids, and to a method for
generating such a culture.
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BACKGROUND OF THE INVENTION
Tuberculosis (TB) remains the leading cause of preventable deaths in the world with 100 million new infections and
two million deaths each year. TB is caused by Mycobacterium
tuberculosis (hereinafter also referred to by the abbreviation
"Mtb"), an acid-fast bacillus that is transmitted primarily via
the respiratory route. The aerosol containing the pathogen is
released from people with active TB when they cough or
sneeze. When a person breathes in the pathogen it enters the
alveolar macrophages via a variety of receptors. Mtb multiplies within the vacuoles in the macrophage, avoids fusion
with the acidic lysosomes and eludes the host defenses. As the
host defense system senses the multiplying pathogen and
mounts its immune defense, the pathogen goes into a nonreplicating, drug-resistant, latent state. The protective
response by the immune system at the site of infection results
in the formation of a granuloma that contains the infection
and prevents its spread. Live bacilli have reportedly been
isolated from granulomas or tubercles in the lungs of persons
with clinically inactive tuberculosis, regarded as the latent
form of TB, indicating that the organism can persist in granulomatous lesions for decades. It is estimated that one-third of
the world population has latent TB. These individuals are
asymptomatic latent carriers who exhibit no signs of disease.
Their risk for reactivation is estimated to be 2-23% over their
life time. One study concluded that a 25 year old with latent
TB has a 7 .3% life time risk of reactivation. The risk increases
dramatically for persons coinfected with HIV, more like 10%
per year. Thus, the advent of AIDS greatly amplified the TB
threat to human health. The deadly partnership between TB
and AIDS, especially with multi- and extremely drug-resistant TB, is contributing to a dramatic rise in TB cases worldwide leading to a grave situation. The emergence and spread
of multi-drug resistant and extremely drug-resistant TB is
widely recognized as a major threat to public health.
The ability of the pathogen to go into the drug-resistant
latent state is a major road block to the eradication ofTB. It is
known that latent Mtb persists in a non-replicating state.
Antibiotics used to treat bacterial infection are usually active
against growing bacteria but not against the dormant pathogen. Correlation between antibiotic activity and bacterial
growth state in streptomycin-dependent Mtb was shown
almost 30 years ago. The antibiotic-resistance of non-growing bacteria is due to changes in bacterial metabolism or
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tutively upregulated along with the dormancy regulator protein DosR. The authors suggested that constitutive accumulation ofTG by this strain may confer an adaptive advantage
for growth in microaerophilic or anaerobic environments and
thus be related to the epidemiological spread of this strain.
Our hypothesis concerning the importance of Rv3130c is
strongly supported by the remarkable finding by our collaborators. A recently developed two step multiplex and real time
PCR method was adapted for reliable quantitative gene profiling of the small amount oflatent Mtb expected to be found
in infected animal and human host lung tissues. Remarkably,
tgsl (Rv3130c) was by far the most upregulated gene in the
pathogen within the host, while dosR and aceAa that are
well-known to be involved in dormancy, were much less
induced. Many organisms use waxy esters (WE) as the major
form of energy storage. Mtb also stores WE but the genes
involved in the synthesis of WE and the growth conditions
that cause its accumulation have not been identified. The
basic mechanisms used for biosynthesis of WE were first
elucidated in our laboratory several decades ago and the enzymatic strategy described more recently. We have recently
shown that Rv33 91 and Rv 1543 encode acy1-CoA reductases
involved in WE synthesis in Mtb. Rv3391 has been reported
to be upregulated under nutrient stress conditions. We found
that WE accumulates under stress conditions that lead to a
dormancy-like state and the accumulated WE is utilized upon
starvation. This utilization was reduced in lip Y mutant, indicating the involvement oflipY in WE hydrolysis. Thus, Mtb
can produce and use both major energy storage forms. TG and
WE, and both forms are likely to be used for successfully
going through dormancy. WE may also be a component of the
cell wall lipids that control permeability.

nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas
phase oxygen level.
The present invention also includes a pure culture, and even
a single isolated cell of resistant Mycobacterium generated
according to the method disclosed.
The invention includes an in vitro model oflatent tuberculosis, the model comprising an isolated culture of THPl
derived macrophages containing ingested Mycobacterium
tuberculosis bacteria and incubated under hypoxic conditions
for a time sufficient for the bacteria to accumulate increased
lipids therein. More broadly, the invention also provides an in
vitro model oflatent mycobacterial infection, the model comprising an isolated culture of THPl derived macrophages
containing ingested Mycobacterium spp. cells and incubated
under hypoxic conditions for a time sufficient for the bacteria
to accumulate increased lipids therein. More broadly still, the
invention teaches an in vitro model of mycobacterial infection, the model comprising an isolated culture of THPl
derived macrophages containing ingested Mycobacterium
spp. cells.
With regard to the various models disclosed in the invention, the teachings also comprise a method of making a model
oflatent tuberculosis, the method including inducing cultured
THPl cells to differentiate into macrophages; infecting the
macrophages with Mycobacterium tuberculosis bacteria; and
incubating the infected macrophages under hypoxia, particularly wherein incubating is for a time sufficient for the bacteria to accumulate increased lipids therein, a hallmark of
latency. This method, in general, should also be applicable to
other Mycobacterium species as well.
The various in vitro models of latent tuberculosis and
mycobacterial infection herein disclosed are useful in evaluating compounds for effectiveness against these bacterial
pathogens.

SUMMARY OF THE INVENTION
With the foregoing in mind, the present invention advantageously provides a method ofinducing latency inMycobacterium, the method comprising growing a pure culture of
Mycobacterium exposed to multiple stress conditions, the
stress conditions including at least a low nutrient culture
medium without glycerol, a low pH, a relatively high level of
carbon dioxide and a relatively low gas phase oxygen level.
A latent culture of Mycobacterium growing in vitro is
particularly useful in evaluating the effectiveness of antimicrobial compounds against this form of the organism, which
is prevalent throughout the world in infected but asymptomatic persons. Before the present invention, it was difficult to
test drug effectiveness against latent Mtb due to the lack of an
easily reproducible model system. Accordingly, the present
invention discloses an in vitro model oflatent mycobacterial
infection which is useful in testing antimicrobials for activity
against the infection in its latent stage.
The method of the invention includes growing the Mtb in a
low nutrient medium comprising approximately 10% Dubas
medium, preferably at a pH of approximately 5 and in an
atmosphere relatively high in level of carbon dioxide, at
approximately 10%. Additionally, the atmosphere includes a
relatively low oxygen level of approximately 5%. Preferably,
in the method, the Mycobacterium is a strain of Mycobacterium tuberculosis.
Another embodiment of the present invention includes a
method of inducing a pure culture of Mycobacterium to
become rifampicin resistant and to store an increased lipid
content, two hallmarks of latency, the method comprising
growing the culture simultaneously exposed to multiple
stress conditions, the stress conditions including at least a low
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Some of the features, advantages, and benefits of the
present invention having been stated, others will become
apparent as the description proceeds when taken in conjunction with the accompanying drawings, presented for solely
for exemplary purposes and not with intent to limit the invention thereto, and in which:
FIG. 1 is a demonstration of the accumulation of storage
lipids in Mtb cells treated for the indicated periods under the
multiple stress conditions, according to an embodiment of the
present invention; TLC was performed as described; the
plates were charred and quantitation was done by densitometry;
FIG. 2 shows increasing lipid storage bodies in Mtb cells
with increasing periods of multiple stress; non-acid fast staining cells (green) and lipid storage body staining (red)
increased with time under multiple stresses; cells were
stained with Auramine-0 and Nile Red and examined by
confocal laser scanning microscopy (Leica TCS SP5) with
Z-stacking to get the depth of the scan field; scanned samples
were analyzed by LAS AF software for image projection;
FIG. 3 shows an increase in the percentage oflipid-stained
cells and decrease in percentage of acidfast stained cells in
Mtb culture when subjected to multiple stresses in vitro;
FIG. 4 depicts TG accumulation by tgsl (Rv3130c) and
restoration of TG accumulation by complementation under
18 days of multiple stress; equal amounts of lipid were subjected to TLC as in FIG. 1; C-lltgsl, is a complemented
mutant;

US 8,551,499 B2
5

6

FIG. 5 shows real-time PCR measurements of transcript
levels oftgs and stress responsive genes in Mtb H37Rv under
in vitro multiple stress for 9 days; comparative Cr method
(llllCr) was used to quantify and values obtained with starting aerated cells were used to calculate the fold induction;
FIG. 6 shows expression profiles of genes encoding proteins involved in the glyoxylate cycle during the multiple
stress treatment;
FIG. 7 depicts a decrease in buoyant density of Mtb cells
subjected to multiple stresses; Mtb cells subjected to the
multiple stresses were placed on the preformed gradient and
centrifuged at 400 g for 20 min; the center tube is a 3 day cell
sample mixed with density marker beads; Percoll® gradients
were self-formed by centrifugation from a starting solution
with a density of 1.0925 gm/ml; the densities of selected bead
layers (p, in gm/ml) are given on the right and the positions of
one ml fractions collected for analyses are at the left; numbers
below the tubes indicate the number of days under multiple
stress:
FIG. 8 is a bar graph showing that Alamar Blue assay
reveals development of Rif resistance by multiple-stressed
Mtb cultures; Mtb cultures subjected to multiple stresses
were assayed by the specially adapted Alamar Blue method
described in text for resistance to Rif and INH; fluorescence
readings above 0 h controls are depicted;
FIG. 9 shows real time PCR measurement of transcripts
levels of a subset of selected dormancy metabolism and stress
responsive genes in Mtb H37Rv under in vitro multiple
stresses for 9 and 18 days; a relative quantitation method
(ddCt) was used with the 7500 Fast real time system; samples
of starter cultures were used as calibrator to calculate the fold
induction:
FIG. 10 are photomicrographs where Oil Red-0 staining
reveals lipid droplet accumulation in TDM incubated for
3-days in 1% 0 2 , 5% C0 2 (a) compared to 0-day control (b );
FIG. 11 indicates the increase in lipid bodies in TDM
infected with Mtb and subjected to hypoxia for 0 and 3-days;
FIG. 12 shows Mtb within TDM stained withAuramine-0
and Nile Red showing spherical fluorescent lipid bodies and
lack of acid fast staining;
FIG. 13 shows that TG accumulated by TDM under
hypoxia is utilized by Mtb; in A, lipids from uninfected (U)
and infected (I) TDM, incubated in 20% 0 2 or 1% 0 2 for 7
days after infection, were resolved on TLC and visualized
under UV light after spraying with 2',7'-dichlorofluorescein;
in B, lipids ofMtb recovered from TDM incubated in 20% 0 2
(i) or 1% 0 2 (ii); solvent was hexane-ether-formic acid (90:
10:1, v/v/v) TG, triacylglycerol, FA, fatty acids;
FIG. 14 depicts the fatty acid composition ofTG from Mtb
recovered after TDM infection; after infection with Mtb,
TDM were incubated under 1% 0 2 for 7 days; TG from Mtb
isolated from TDM was purified by preparative TLC. Fatty
acid methyl esters were prepared from Mtb TG and analyzed
using a Varian CP-TAP CB column attached to a Varian
CP-3900 gas chromatograph under a temperature control program;
FIG. 15 depicts transcriptional profiling of genes in Mtb
H37Rv from infected TDM under hypoxia;
FIG. 16 shows that Mtb inside [14C]acetate-labeled lipidloaded macrophages mobilizes host lipids and accumulates
TG enriched in saturated fatty acids; in A, AgN0 3 -impregnated silica-TLC purified from [1 4 C]acetate-labeled lipids of
infected macrophages (lane 1) and from Mtb recovered from
such macrophages (lane 2); solvent system is 1% methanol in
chloroform; in B, is shown reversed-phase TLC analysis of
fatty acids methyl esters of TG from infected macrophages
(lane 1) and from Mtb recovered from infected macrophages

(lane 2); the solvent system is acetonitrile:methanol:water:
acetic acid (30:70:5:1, by volume); in C. AgN0 3 -impregnated silica-TLC of fatty acids methyl esters of TG from
infected macrophages (lane 1) and from Mtb recovered from
infected macrophages (lane 2); the solvent system is hexane:
diethyl ether:acetic acid, 94:4:2, v/v/v, (developed twice);
FIG. 17 shows TDM infected with Mtb and incubated
under hypoxia appear to fuse together; TDM infected with
Mtb at an MOI of0.1 and incubated for 7 days under 1% 0 2
were stained with carbolfuschin followed by hematoxylin
and eosin (A) or carbolfuschin followed by methylene blue
(B); arrows show Mtb; and
FIG. 18 shows Mtb inside TDM that accumulate neutral
lipids lose acid-fastness; intact TDM harboring Mtb were
fixed with 4% paraformaldehyde overnight and stained with
the fluorescent mycolic acid staining dye Auramine-0 (A)
followed by the neutral lipid stain Nile Red (B); Mtb stained
strongly for Nile Red but weakly for Auramine-0.
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DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENT
The present invention will now be described more fully
hereinafter with reference to the accompanying drawings, in
which preferred embodiments of the invention are shown.
Unless otherwise defined, all technical and scientific terms
used herein have the same meaning as commonly understood
by one of ordinary skill in the art to which this invention
pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or
testing of the present invention, suitable methods and materials are described below. Any publications, patent applications, patents, or other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the
present specification, including any definitions, will control.
In addition, the materials, methods and examples given are
illustrative in nature only and not intended to be limiting.
Accordingly, this invention may be embodied in many different forms and should not be construed as limited to the illustrated embodiments set forth herein. Rather, these illustrated
embodiments are provided so that this disclosure will be
thorough and complete, and will fully convey the scope of the
invention to those skilled in the art. Other features and advantages of the invention will be apparent from the following
detailed description, and from the claims.
With the foregoing in mind, an in vitro dormancy model
that can be adapted to drug screening would help to discover
antilatency drug candidates. in vitro models suitable for such
screening are urgently needed. A number of different stresses
have been applied to Mtb in vitro in an attempt to generate a
dormant state and gene expression changes have been investigated. Most of these models involve single stress factors
such as oxygen depletion, nutrient deprivation, NO treatment
and acidic conditions. The gene expression changes during
combined nutrient deprivation and 10% and 0.2% oxygen
stress on stationary phase cultures were investigated. Some of
these stress conditions such as prolonged nutrient starvation
caused Mtb to become highly Rif-resistant but accumulation
of storage lipids was not tested. On the other hand hypoxic
conditions we used that caused TG accumulation did not
develop resistance to 5 µg/ml Rif (unpublished). The Neuropilin-1 (NRP-1) condition was reported to cause resistance to
a lower concentration ofRif(l µg/ml) but lipid accumulation
was not tested. We suggest that both Rif-resistance and lipid
storage are hallmarks of dormancy. Since individual stress
conditions do not allow the pathogen to fully meet these
criteria, we attempted to mimic the in vivo conditions by
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applying multiple stresses thought to be encountered in vivo
by Mtb and tested whether the pathogen would accumulate
storage lipids and develop Rif-resistance. Bacilli within
granulomas encounter low oxygen (5%) but not hypoxia,
high C0 2 (10%) concentrations, low nutrient levels and acidic
pH. Based on these reports, we used 5% 0 2 , 10% C0 2 , pH 5 .0
and 10% Dubas medium in a multiple stress in vitro model.
Our preliminary results show that the combination of the four
stress factors leads to accumulation of storage lipids (TG and
WE), development of Rif-resistance and gene expression
changes thought to be associated with dormancy. Some of the
gene expression changes are similar to those found in the
pathogen from infected lungs ofhosts, including primates and
a human TB patient.

TABLE 1

Both Rif-resistance and storage lipid accumulation are
associated with dormancy. However, the commonly used in
vitro hypoxia model, does not show both of these characteristics. Therefore we developed a novel multiple stress model
that applies four different stresses that the pathogen is thought
to encounter in the host. We grew Mtb cultures in low pH (pH
5.0), low nutrient (10%) Dubas medium without glycerol,
with high (10%) C0 2 and low (5%) oxygen gas phase.
Mtb cultures in 10%Dubos (Difco)mediumatpH 5.0atan
OD 600 of 0.2 were maintained under 5% 0 2 +10% C0 2 +
85% N 2 by replacing the air phase every other day; oxygen
levels did not change significantly during the two day period.
After monitoring the progressive changes that happened to
the pathogen, we chose to harvest cells at 3, 9 and 18 days
under such conditions for more detailed studies. These studies included examination of storage lipids, antibiotic (Rif and
INH)-resistance, gene expression changes directly relevant to
storage lipid synthesis by quantitative real time PCR (qPCR),
and gene expression profiles by microarray analyses. TLC
showed that WE and TG accumulated under the multiple
stress conditions reaching near maximal levels by 9 days FIG.
1.
The major wax ester was oleyl oleate and the major fatty
acids in the TG were C16 and C18 with less C26 (data not
shown). Under these conditions more WE accumulated than
TG in absolute amounts. Control samples at pH 7 .0 or pH 5 .0
without additional stress showed no increase in storage lipids.
Nile red staining revealed storage lipid accumulation under
the multiple stress conditions. It is well known that Mtb
cultures contain a heterogeneous population of cells under
different physiological states. As the culture was subjected to
multiple stress factors we observed decrease in acid fast staining cells with increasing lipid body staining cells from a
barely detectable level to a significant percentage of the total
cells by 18 days (FIGS. 2, 3).
Drug resistance was tested by treatment with 5 µg/ml Rif
for 5 days followed by serial dilution and plating. By 9 days
about 10% of the cells were found to be Rif resistant whereas
the starting culture contained about 0.03% Rif-resistant cells.
Rif-resistance increased up to 18 days, sometimes reaching
up to 25% at 5 µg/ml Rif. The tgsl (Rv3130c) disruption
resulted in the loss ofRif-resistance which was restored in the
complemented mutant (Table 1). Hypoxic conditions, that
were previously found to cause accumulation of storage lipids, did not cause the cells to develop detectable Rif-resistance at 5 µg/ml. The tgsl (Rv3130c) disruption resulted in
loss of TG accumulation under multiple stress. However the
complemented mutant showed a level of TG accumulation
comparable to the wild type (FIG. 4).

Development ofRif-resistance in wild type H37Rv but not
in Rv3130c mutant upon application of multiple stress:
complementation restores Rif-resistance. Aliquots were either
untreated or treated witb Rif (5 µg/ml) or !NH (0.8 µg/ml).
Resistance to
Antibiotics(%)

Mtb
strains

Days

!NH (0.8 µg/ml)

Rif (5.0 µg/ml)

WT-H37Rv

0
9
18
0
9
18
0

0.034
34.7
84.4
0.011
21.1
31.2
0.041

0.037
4.7
12.5
0.025
1.16
1.89
0.029

10

L\.-Rv3130c
(L\.-tgsl)
15

Comple-L\.Rv3130c

day
day
day
day
day
day
day

9 day
18 day

(±0.02)
(±12)
(±17.5)
(±0.01)
(±7.8)
(±13.1)
(±0.02)

37.9 (±13.5)
091 (±19)

(±0.027)
(±1.9)
(±3.4)
(±0.019)
(±0.87)
(±0.9)
(±0.01)

5.2 (±2.1)
011 (±4.5)

ND, Not determined;
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Gene expression changes directly relevant to storage lipid
accumulation were examined by real-time PCR. Among all
the tgs genes, induction of tgsl (Rv3130c) was by far the
highest at 9 days under the multiple stress condition, followed
by Rv3371 and Rv3088 (FIG. 5). Microarray analysis also
indicated upregulation ofRv3371 under multiple stress condition (data not shown). Upregulation of Rv3088 probably
resulted from the low pH as it has been previously reported to
be induced under acidic stress. Up-regulation of Rv3371 is
noteworthy as it was also shown to be up-regulated in human
lung granuloma by microarray analysis. The degree of induction oftgsl (Rv3130c) was comparable to that of icl and acr
(hspX), genes previously reported to be induced during persistence. Our preliminary experimental results raise the possibility that lipid accumulation under different stress conditions might use different sets oftgs genes.
The TIGR Pathogen Functional Genomics Resource Center provided the Mtb genome microarray for this study. Under
our multiple stress condition, genes that encode enzymes
involved in glyoxylate cycle such as isocitrate lyase (aceA)
and citrate synthase (gltAl) showed significant increase in
expression for all time points examined (FIG. 6). From these
data we infer that the metabolic regulation of cells adapting to
the multiple stresses was similar to that observed in persistent
bacilli adapting to the phagosomal environment of a macrophage. Under multiple stresses, Mtb showed shutdown of
both ATP/NAD energy regeneration systems. While gene
expression for anaerobic respiration was continuously
increased at the later time points, the aerobic respiration was
significantly repressed at all the time points. All the subunits
encoding NADH dehydrogenase and the ubiquinol-cytochrome C complex were repressed more than 2-fold. In addition, the expression of the genes encoding ATP synthase
subunits was repressed. Slowdown of the transcription/translation apparatus was evident during the multiple stresses.
Many genes related to transcription and translation apparatus
were all consistently repressed. Genes involved in modification of chromosome and cell division were repressed by the
multiple stresses. The expression level of the gene cluster,
mas, fad28, mmpL7, and ppsA-E, associated with phthiocerol dimycocerosate (PDIM) synthesis and transport, that
was repressed at the beginning of the multiple stress treatment, gradually increased more than two-fold and remained
high throughout the period of in vitro multiple stress. Further,
the mas-like gene pks2, which is responsible for encoding a
hepta/octa-methyl branched fatty acid synthase, was highly
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expressed. These changes are consistent with the report that
dormant cells have thickened walls. We also found significant
induction of the genes classified as the stress response genes
(eg. hspX) that has been suggested to play a role in maintaining long term survival within the host. The gene array analysis
results were verified by qPCR analysis of selected test genes.
Repressed and induced gene transcript level changes indicated by microarray analysis were found to be consistent with
the changes indicated by the qPCR method (data not shown).
We investigated whether the lipid accumulation that occurs
as a result of multiple stresses might be reflected in changes in
buoyant density. We fractionated the culture on a Percoll®
gradient in 10 ml Seton Easy-Seal polyallomer centrifuge
tubes with Seton Noryl crown assembly. This procedure
resolved cells based on buoyant density (FIG. 7). The banding
pattern changed as the cultures were subjected to multiple
stresses for increasing duration. These changes are consistent
with the conclusion that application of multiple stresses
caused progressive changes in lipid accumulation resulting in
increasing percentages of cells in the lighter fractions.
Auramine-0/Nile Red staining of the different fractions
showed that with increasing periods under the multiple
stresses, increasing percentage of cells became lipid-loaded
and lost acid-fast staining (presumably dormant cells). Staining of Percoll® fractions from 18 day stressed cultures
showed that the lighter fractions were more enriched in, lipid
loaded cells that lost acid-fastness. After this long stress
period most cells were in the lighter fractions (FIG. 7). Upon
Percoll® density gradient fractionation of the 18-day multiple-stressed culture, the great majority of the cells were
distributed in the lighter fractions. When Rif-resistance was
assessed by the Alamar Blue dye method the lighter fractions
showed a higher percentage of Rif-resistant cells (data not
shown). The small number of heavier cells present in this
culture showed Rif-susceptibility comparable to that of the
starting culture.
Recent meta-analysis ofMtb microarray data from many in
vitro and in vivo conditions that are thought to induce dormancy (Murphy and Brown, BMC Infect. Dis. I, 84-100,
2007) indicated that a set of genes possibly involved in lipid
storage and utilization are highly upregulated. We have determined the transcriptional profile of the genes, selected on the
basis of the meta-analysis by real-time PCR using 7500 Fast
system (Applied Biosystem). Detection of transcriptional
upregulation of the known dormancy-responsive genes such
as hspx, icl and dosR (FIG. 1) is consistent with our conclusion that the multiple stress conditions induce dormancy.
Seven of the 10 genes in the first priority group, such as
Rv3130c along with a few othertgs genes (Rv3371, Rvl 760),
a few genes encoding potential hydrolases (lipX lipY, cut3),
and fatty acy1-CoA reductase gene (Rv33 91) showed upregulation. Three of the 21 genes in the next priority group showed
upregulation under the multiple stress condition. One of them
showed surprisingly high induction. The other two upregulated genes in this group were cut2 and lipZ. Only one gene
(Rv2285, a tgs) in the third priority group showed upregulation. Among the tgs products that showed the highest enzymatic activity (when expressed in E. coli) only this tgs
showed a preference for oleoyl-CoA. We already have mutant
for this gene and this mutant showed the second most
impaired ability to accumulate TG under hypoxia as indicated
in the preliminary results presented in the application.
It is noteworthy that 7 of the 10 genes in the first priority
group and 3 out of 21 genes from the second priority group
and only one out of 17 in the third priority group showed
upregulation. Since the prioritization is based on meta-analysis of the degree of their upregulation under a variety of

conditions thought to induce dormancy, our results suggest
that the multiple stress model reflects real dormancy and adds
validity to our approach.
The tuberculous granuloma, which is thought to be a
hypoxic environment, consists of a core ofMtb-infectedmacrophages surrounded by lipid-loaded macrophages, mononuclear phagocytes and lymphocytes enclosed by a fibrous
cuff. The differentiation of macrophages into lipid-loaded
macrophages in tuberculous granulomas is a well-documented observation and the secretion of cytokines by the
infected lipid-loaded macrophages probably helps to maintain the granuloma.
Histological studies revealed the presence of lipid-loaded
macrophages in the granulomas of immunocompetent and
HIV-1 infected patients with TB. Lipid-loaded macrophages
contain abundant cytosolic stores of TG and cholesterol
esters. A recent study showed that exposure of human macrophages to hypoxia (1 % 02) converted them into lipidloaded cells and M. bovis BCG infection induced the conversion of macrophages into lipid-loaded cells but the
nonpathogenic Mycobacterium smegmatis failed to induce
lipid body formation. Thus lipid bodies within Mtb-infected
macrophages may have important roles in pathogenesis and
possibly in latency. Human THP-1 monocytic cell line-derived macrophages (TDM) are known to be converted into
lipid-loaded macrophages. Therefore they can serve as a more
convenient experimental model for studies on Mtb mutants,
because their use can avoid the variability in responses
encountered in the use of human peripheral blood monocytederived macrophages and provide a readily available uniformly reproducible cell model suitable for high throughput
screening of drug candidates. Lipid bodies have been found in
Mtb obtained from patients with active disease. However, the
origin of these lipids remains unknown. The pathogen inside
the lipid-loaded macrophages might utilize fatty acids
derived from the lipid bodies in the host cells to store lipids
within Mtb for later use. Such a possibility was raised by the
recent finding that adipocytes might be a home for dormant
Mtb in humans. In fact, Mtb inside adipocytes were found to
accumulate lipid bodies while becoming dormant, as indicated by their resistance to killing by drugs. The lipid bodies
found in the pathogen from patients probably originate from
the lipid bodies in the macrophages. Our results indicate that
Mtb within lipid-loaded macrophages can use the host's TG
to accumulate TG within the pathogen and this Mtb becomes
Rif resistant meeting our criteria for dormancy.
A New Lipid-Loaded Macrophage Model of Dormancy
Herein we disclose a newly developed THP-1 derived macrophage (TDM) system for infection with Mtb. THP-1 cells,
differentiated into macrophages by treatment with 100 nM
PMA for 3 days, were incubated for 3 days in 1% 02 and 5%
C02. Oil Red-0 staining revealed lipid droplet accumulation
in such macrophages (FIG. 2). When the TDM were infected
with Mtb at a multiplicity of infection (MOI) of 1.0 for 4 hr
and incubated in 1% 0 2 /5%/C0 2 for 3 days, lipid bodies
accumulated in the host cells (FIG. 3). Mtb cells within the
macrophages showed Nile Red stained lipid bodies (FIG. 4).
Most Mtb cells showed loss of acid fast staining and thus
stained only red; a few showed some acid fast and lipid
staining (yellow).
We modified our experimental protocol to allow for longer
incubation of infected macrophages. We infected TDM with
Mtb at an MOI of0.1 (1 bacillus per 10 macrophages) and
extended the incubation of the infected TDM to 7 days under
hypoxia. After 7 days, infected TDM were lysed and the cell
debris was removed by centrifugation at 300 g for 10 min. The
Mtb cells were pelleted by centrifugation at 3000 g for 10 min
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and washed. Lipids from the host-lipid bodies were extracted
from the supernatant and the lipids from the pelleted To
analyze fatty acid composition, host or Mtb TG was purified
by preparative TLC and the methyl esters generated by BF3/
methanol transesterification, were analyzed by capillary GC.
The amount of fatty acids from the TG isolated from Mtb,
recovered for TDM, is more than enough for such GC analysis (FIG. 12) pathogens were extracted. TLC analysis of the
lipids revealed that TG in the host cells was markedly
increased by incubation under hypoxia for 7 days and the
levels of TG were lower in infected TDM under hypoxia
(FIG. 13A). Lipids extracted from Mtb recovered from
infected TDM were also analyzed by TLC. We detected
increased TG level in Mtb cells recovered from TDM incubated under hypoxic conditions (FIG. 13B).
The fatty acid composition of the TG from the pathogen
was not identical to that of the host TG. Cl 6:0, Cl 8:0 and
Cl 8: 1 fatty acids were the dominant components in both the
pathogen and the host. Longer chain saturated fatty acids
(C24. C26 and C28) that were present in the pathogen TG
were absent in the host TG. We conclude that the TG that
accumulated in the pathogen probably consisted of fatty acids
from the host and some fatty acids generated within the pathogen.
Gene expression changes occurring in the pathogen within
TDM were examined using a two-step real time PCR method.
Briefly, total RNA was isolated and purified from a mixture of
Mtb-infected TDM using Trizol (Invitrogen) and Qiagen
RNeasy colunm purification method. Total RNA was DNase
treated twice, purified through Qiagen mini elute RNeasy
colunm, purity of RNA was checked at every step. Controls
without reverse transcription (RT) verified lack of DNA contamination. First-strand cDNA, synthesized with exo-resistant random hexamers and Superscript III reverse transcriptase (Invitrogen) was used for multiplex PCR using
many Mtb gene specific primer sets. All primers and Taqman
probes were designed using VisualOMP6 software from
DNA software, Inc (Ann Arbor, Mich.). The Taqman probes
have a fluorescein reporter dye (FAM) at 5'-end and a Black
Hole Quencher (BHQ) at 3'-end. Each multiplex and realtime PCR primer was checked for specificity and efficiency.
Differences in Mtb specific gene transcripts were quantified
by real-time PCR on generated multiplex-PCR products with
nested Taqman primers and probes. The overall reliability and
sensitivity of the two-step RT-PCR method to quantify gene
expression profiling has been discussed in detail elsewhere.
We have thus far done only a subset of genes thought to be
relevant to lipid storage and metabolism (FIG. 7); icl was by
far the most induced gene, consistent with the idea that the
pathogen in TDM grows on fatty acids. It is noteworthy that
lip Y, that was previously shown by us to be involved in TG
mobilization, was highly induced and some of the other lip
genes also showed induction. dosR and tgs genes were also
induced probably indicating their involvement in the storage
of fatty acids derived from host-lipids as TG resynthesized
within the pathogen, consistent with our hypothesis. fatp, that
might be involved in fatty acid transport into the pathogen
was also induced. Putative fabp genes also showed some
induction. These results indicate that our hypothesis concerning storage and mobilization of host lipids by the pathogen
has real validity.
We analyzed the resistance of Mtb recovered from TDM
after a 7 day incubation under 20% 0 2 or 1% 0 2 to Rif and
INH by cfu determination. TDM were infected with Mtb at an
MOI ofO.l. Mtb cells inside TDM were exposed to antibiotic
for 2 days prior to lysis ofTDM and recovery of the bacilli.
The recovered Mtb cells were diluted and plated on agar

plates without antibiotic and incubated for 4 weeks after
which cfus were enumerated. Antibiotic resistance is
expressed as percentage of control without antibiotic. As
indicated in Table 2, Mtb recovered from TDM incubated
under 20% 0 2 showed resistance to both antibiotics. Others
have found development of Rif resistance in host cells. We
found that Rif resistance increased significantly in Mtb recovered from TDM incubated under 1% 0 2 for 7 days compared
to normoxic conditions. These results indicate support for our
hypothesis that lipid-loading of macrophages favor the entry
ofMtb into dormancy.
Lipid-Loaded Macrophage Model
In making further progress developing the macrophage
dormancy model, we tested different MOI in the lipid loaded
macrophage system. We assessed the viability of Mtb-infected lipid-loaded macrophages under hypoxia under different MOL At MOI 1.0 or higher the host cell viability was
seriously compromised. At MOI 0.1, after 7 days under 1%
0 2 , 40% of the original TDM population remained intact as
an adhered monolayer and were loaded with lipid droplets.
About 94% of these lipid-loaded TDM cells in the adhered
mono layer were viable. These results support the notion that
these lipid-loaded TDMs provide a TG-enriched sanctuary
for Mtb, favoring its entry into dormancy.
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Increase in resistance ofMtb inside lipid-loaded macrophages to Rif
and !NH. Mtb within TDM incubated for 7 days under 20% 0 2 or 1% 0 2
was exposed to antibiotic for 2 days. Mtb cells were then recovered by
lysis ofTDM and plated on agar plates for cfu determination.
Resistance to
Antibiotic

Mtb recovered from
35 TDM incubated

!NH

Rif

7 days in

1 µg/ml

5 µg/ml

0.1 µg/ml

0.8 µg/ml

20%02
1%02

9%
68 ± 14%

4%
25 ± 2%

25%
100%

12%
68 ± 18%
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We originally suspected that Mtb utilizes the macrophage
lipid bodies to acquire fatty acids and store them as TG within
the pathogen to enable it to go through dormancy. To test this
hypothesis, we labeled TDM lipids by incubating the cells
with [ 14C]acetic acid or [ 14C]oleic acid, under 1% 0 2 for 2
days. These cells were washed three times with sterile phosphate-buffered saline (PBS) to remove unincorporated radiolabel. Thin-layer chromatographic (TLC) analysis of the
labeled lipids extracted from TDM showed that major part
(about 60%) of the radioactivity in the lipids derived from
labeled acetate and oleate was in TG that accumulated in
TDM under 1% 0 2 . These pre-labeled cells were infected
with Mtb at an MOI of 0.1 for 4 h under 1% 0 2 . Following
infection, extracellular Mtb were removed by thoroughly
washing the TD M monolayer with sterile PBS. Infected TD M
were incubated for 5 more days under 1%0 2 . The host lipids
and lipids from Mtb recovered from the host cells were
obtained and the lipids were analyzed by TLC. The fatty acid
composition of the Mtb and host TGwas analyzed by resolving the intact TG and fatty acid methy1esters derived from TG
on reversed-phase silica-TLC and argentation-TLC. Analysis
of intact TG from [1 4 C]acetate in TDM was composed of
saturated and unsaturated fatty acids. However, the TG ofMtb
was predominantly composed of saturated fatty acids as indicated by greater mobility onAgN0 3 -impregnated TLC (FIG.
16A). Analysis of fatty acid methyl esters prepared from TG
isolated from TDM and Mtb indicated that the TG of Mtb,
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recovered from TDM labeled with [ 14C]acetate, was composed primarily of saturated fatty acids, mostly 14C-l 6:0 and
a very small quantity of 14C-18:0 fatty acids (FIG. 16 B,C).
See also Table 3, below.

lation of neutral lipids and loss of acid-fastness by a subset of
Mtb ce!ls within lipid-loaded TDM under hypoxia, correlates
well with our data in the Preliminary Results, that demonstrated the development ofRif resistance by about 25% of the
Mtb population and increase in TG within Mtb from TDM
under the same conditions. Since then, we have reconfirmed
these results with additional experiments.
Based on these results, the multiple stress in vitro latency
model disclosed herein appears to be the best one available for
screening chemicals to discover drug candidates that can
eliminate latent pathogen. Accordingly, in the drawings and
specification there have been disclosed typical preferred
embodiments of the invention and although specific terms
may have been employed, the terms are used in a descriptive
sense only and not for purposes of limitation. The invention
has been described in considerable detail with specific reference to these illustrated embodiments. It will be apparent,
however, that various modifications and changes can be made
within the spirit and scope of the invention as described in the
foregoing specification and as defined in the appended
claims.
What is claimed is:
1. An in vitro model oflatent tuberculosis, the model comprising an isolated culture of THPl derived macrophages
containing ingested Mycobacterium tuberculosis bacteria
and incubated under hypoxic conditions of 5% 0 2 or lower
and 5% C0 2 or higher for a time sufficient for the bacteria to
accumulate increased lipids therein.
2. A method of evaluating a compound for effectiveness
against latent tuberculosis, the method comprising contacting
the in vitro model of claim 1 with the compound and comparing the model in the presence and in the absence of the
compound.
3. An in vitro model oflatent mycobacterial infection, the
model comprising an isolated culture ofTHPl derived macrophages containing ingested Mycobacterium sp. cells and
incubated under hypoxic conditions of 5% 0 2 or lower for a
time sufficient for the bacteria to accumulate increased lipids
therein.
4. A method of evaluating a compound for effectiveness
against latent mycobacterial infection, the method comprising contacting the in vitro model of claim 3 with the compound and comparing the model in the presence and in the
absence of the compound.
5. A sample of Mycobacterium tuberculosis cells produced
by a method comprising growing a pure culture of Mycobacterium tuberculosis exposed to a plurality of stress conditions, the stress conditions being a low nutrient culture
medium without glycerol, wherein said low nutrient medium
is comprised of a 10% Dubas medium or less a low pH
wherein said low pH is a pH of 5 or less, a relatively high level
of carbon dioxide, wherein said relatively high level of carbon
dioxide is 5% or higher, and a relatively low gas phase oxygen
level, wherein the relatively low oxygen level is 5% or lower.
6. A method of evaluating a compound for effectiveness
against mycobacterial infection, the method comprising contacting the sample of claim 5 with the compound comparing
the cells in the presence and in the absence of the compound;
and
determining whether the compound is effective against
Mycobacterium tuberculosis cells.

TABLE3
Accumulation of radio labeled TG by Mtb and mutants
in lipid-loaded macrophages under hypoxia:
DPM in TG % of WT
14

C-Acetate

14

C-Oleate

WT
L\.Rv3130c
WT
L\.Rv3130c

210,000
22,600
29,000
1470

10

100%
11%
100%
5%

Mtb recovered from [ 14C]oleic acid-labeled TDM had TG
that was distinctly different in fatty acid composition from the
TG in TDM. While the 14C in TDM TGwas predominantly in
18:0 (about 81% of total fatty acids), 14C in Mtb TG was
mainly in unsaturated fatty acids (about 70% of total fatty
acids). The identity of these fatty acids is to be determined.
These results clearly indicate that Mtb acquires fatty acids
from TDM lipid bodies for synthesizing TG as a potential
energy source. The TG stored within the pathogen probably
includes the fatty acids from the host lipids and fatty acids
generated by modification and/or catabolism and resynthesis.
The biochemical processes involved can be deduced only
after further characterization of the TG that accumulates in
the host and in the pathogen.
We also postulated that the Mtb tgs gene products may be
pivotally involved in synthesizing TG within the Mtb cell
from fatty acids acquired from host TG. To test this hypothesis, we infected the pre-labeled TDM with wild-type Mtb
and tgsl (Rv3130c) deletion mutant (ARv3130c) as
described in the methods section. About 1% of the radio label
in the TG in TDM was found in the TG isolated from Mtb. We
quantitated the radioactivity in the TG of Mtb and fl v3130c
recovered from TDM. The results indicate that TG accumulation by the 43130c was decreased by 90-95% when compared to the wild-type (Table 3). These results additionally
suggest that Rv3130c plays an essential role in the accumulation of TG by Mtb within lipid-loaded macrophages.
In order to visualize the Mtb inside lipid-loaded host cells
infected TDM after 7 days under hypoxia were fixed with 4%
paraformaldehyde and stained for Mtb with carbolfuschin
followed by methylene blue or hematoxylin and eosin to stain
the host cell. Mtb inside TDM were also stained with the
mycolic acid-specific fluorescent dye Auramine-0 followed
by Nile Red which stains neutral lipids. Interestingly, as seen
in FIG. 17, the Mtb-infected TDM which were incubated
under hypoxia for 7 days appeared to be fusing together. It is
probable that these TDM are in the process of forming multinucleate giant cells (asteriskinFIG.17A) which are known to
be present in the hypoxic environment of the granuloma in
close vicinity to lipid-loaded macrophages. These observations support the hypothesis that this lipid-loaded macrophage system is a good model for in vivo latency.
Individual Mtb cells inside TDM that accumulated neutral
lipids, as indicated by Nile Red staining, lost acid-fastness as
shown by weak or total loss of Auramine-0 staining (FIG.
18). Conversely, Mtb cells which stained strongly with
Auramine-0 did not accumulate neutral lipids. This accumu-

15

20

25

30

35

40

45

50

55

60

* * * * *

